Fiche société
Stoke Therapeutics, Inc
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications2liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| zorevunersenThe purpose of the study is to evaluate the efficacy, safety, and tolerability of zorevunersen in Patients with Dravet syndrome. | Épilepsie | Phase 3 | À vérifier | United States, China, France, Germany, Italy, Japan, Spain, United Kingdom | À vérifier |
| zorevunersenThe purpose of the study is to evaluate the efficacy, safety, and tolerability of zorevunersen in Patients with Dravet syndrome. | Épilepsie | Phase 3 | À vérifier | United States, China, France, Germany, Italy, Japan, Spain, United Kingdom | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| zorevunersen | Épilepsie | Phase 3 | NCT06872125 | A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome | RECRUITING |
Publications
2| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| zorevunersen | Zorevunersen in Children and Adolescents with Dravet Syndrome. | The New England journal of medicine | ||
| zorevunersen | Zorevunersen in Children and Adolescents with Dravet Syndrome. Reply. | The New England journal of medicine |